These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 37655704)

  • 1. Chicago Classification v4.0 Stratifies Acid Burden and Abnormal Impedance-pH Variables Better Than Chicago Classification v3.0 Chicago Classification v4.0 and GERD.
    Ribolsi M; Marchetti L; Savarino E; Gyawali CP; Cicala M
    Am J Gastroenterol; 2024 Jan; 119(1):206-209. PubMed ID: 37655704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. From Chicago classification v3.0 to v4.0: Diagnostic changes and clinical implications.
    Sallette M; Lenz J; Mion F; Roman S
    Neurogastroenterol Motil; 2023 Jan; 35(1):e14467. PubMed ID: 36314395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ineffective esophageal motility in Chicago Classification version 4.0 better predicts abnormal acid exposure.
    Zhuang QJ; Tan ND; Zhang MY; Chen SF; Luo Y; Xiao YL
    Esophagus; 2022 Jan; 19(1):197-203. PubMed ID: 34378104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of esophageal motility disorder symptoms with Chicago classification versions 3.0 and 4.0 using high-resolution esophageal manometry: A single-center experience from Saudi Arabia.
    Alzahrani MA; Alfahadi MA; Alshehri MA; Alamri AH; Almahjani EA; Alahmari AM; Al-Shahrani AA; Alshahrani AS; Almanjahi IM; Alqarni AM
    Saudi J Gastroenterol; 2024 Mar; 30(2):96-102. PubMed ID: 37602637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chicago Classification Version 4.0 Improves Stratification of Ineffective Esophageal Motility Patients into Clinically Meaningful Subtypes: A Two-Center International Study.
    Carmel M; Cohen DL; Hijazi B; Azzam N; Khoury T; Pagliaro M; Pesce M; Mari A
    Dysphagia; 2024 Jun; 39(3):444-451. PubMed ID: 37934251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ineffective esophageal motility: The impact of change of criteria in Chicago Classification version 4.0 on predicting outcome after magnetic sphincter augmentation.
    Riccardi M; Eriksson SE; Tamesis S; Zheng P; Jobe BA; Ayazi S
    Neurogastroenterol Motil; 2023 Sep; 35(9):e14624. PubMed ID: 37278157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparing Patients Diagnosed With Ineffective Esophageal Motility by the Chicago Classification Version 3.0 and Version 4.0 Criteria.
    Tuan AW; Syed N; Panganiban RP; Lee RY; Dalessio S; Pradhan S; Zhu J; Ouyang A
    Gastroenterology Res; 2023 Feb; 16(1):37-49. PubMed ID: 36895699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Benefit of extending the protocol for high resolution manometry according to the version 4.0 of the Chicago criteria. A multicenter study.
    Alcalá-González LG; Ezquerra-Duran A; Aguilar A; Barber C; Barba E; Araujo IK; Marin I; Naves J; Serra J
    Neurogastroenterol Motil; 2023 Mar; 35(3):e14503. PubMed ID: 36443930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Characteristics of Patients With Ineffective Esophageal Motility by Chicago Classification Version 4.0 Compared to Chicago Classification Version 3.0.
    Kurin M; Adil SA; Damjanovska S; Tanner S; Greer K
    J Neurogastroenterol Motil; 2023 Jan; 29(1):38-48. PubMed ID: 36606435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prevalence of gastroesophageal reflux disease in named manometric patterns of dysmotility according to the Chicago Classification 4.0.
    de Padua F; Herbella FAM; Patti MG
    Dis Esophagus; 2022 Oct; 35(10):. PubMed ID: 35470401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Indications of 24-h esophageal pH monitoring, capsule pH monitoring, combined pH monitoring with multichannel impedance, esophageal manometry, radiology and scintigraphy in gastroesophageal reflux disease?
    Vardar R; Keskin M
    Turk J Gastroenterol; 2017 Dec; 28(Suppl 1):S16-S21. PubMed ID: 29199161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Are the Chicago 3.0 manometric diagnostics consistent with Chicago 4.0?
    Tobón A; Hani AC; Pulgarin CD; Ardila AF; Muñoz OM; Sierra JA; Cisternas D
    Dis Esophagus; 2024 Apr; 37(4):. PubMed ID: 38117958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postreflux swallow-induced peristaltic wave index from pH-impedance monitoring associates with esophageal body motility and esophageal acid burden.
    Rogers BD; Rengarajan A; Ribolsi M; Ghisa M; Quader F; Penagini R; de Bortoli N; Mauro A; Cicala M; Savarino E; Gyawali CP
    Neurogastroenterol Motil; 2021 Feb; 33(2):e13973. PubMed ID: 33249687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chicago classification v4.0 protocol improves specificity and accuracy of diagnosis of oesophagogastric junction outflow obstruction.
    Visaggi P; Ghisa M; Del Corso G; Baiano Svizzero F; Mariani L; Tolone S; Frazzoni M; Buda A; Bellini M; Savarino V; Penagini R; Gyawali CP; Savarino EV; de Bortoli N
    Aliment Pharmacol Ther; 2022 Aug; 56(4):606-613. PubMed ID: 35751633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gastroesophageal reflux disease and chronic cough: A possible mechanism elucidated by ambulatory pH-impedance-pressure monitoring.
    Li X; Lin S; Wang Z; Zhang H; Sun X; Li J; Wu D; Ke M; Fang X
    Neurogastroenterol Motil; 2019 Dec; 31(12):e13707. PubMed ID: 31482661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ineffective esophageal motility: clinical, manometric, and outcome characteristics in patients with and without abnormal esophageal acid exposure.
    Shetler KP; Bikhtii S; Triadafilopoulos G
    Dis Esophagus; 2017 Jun; 30(6):1-8. PubMed ID: 28475749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between esophageal motility and severity of gastroesophageal reflux disease according to the Los Angeles classification.
    Liu L; Li S; Zhu K; Yu W; Wang H; Guo J; Gao H
    Medicine (Baltimore); 2019 May; 98(19):e15543. PubMed ID: 31083209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Effect of Ineffective Esophageal Motility on Gastroesophageal Reflux Disease.
    Kasamatsu S; Matsumura T; Ohta Y; Hamanaka S; Ishigami H; Taida T; Okimoto K; Saito K; Maruoka D; Nakagawa T; Katsuno T; Fujie M; Kikuchi A; Arai M
    Digestion; 2017; 95(3):221-228. PubMed ID: 28343226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenotyping patients with borderline elevated esophageal acid exposure.
    Reddy CA; Wenzke K; Watts LS; Armstrong M; Chen VL; Baker JR; Chen JW
    Dis Esophagus; 2022 Apr; 35(4):. PubMed ID: 34607359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of proton pump inhibitor-resistant nonerosive reflux disease by esophageal manometry and 24-hour esophageal impedance and pH monitoring.
    Kawamura O; Hosaka H; Shimoyama Y; Kawada A; Kuribayashi S; Kusano M; Yamada M
    Digestion; 2015; 91(1):19-25. PubMed ID: 25632912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.